发明名称 ABT-263 CRYSTALLINE FORMS AND SOLVATES FOR USE IN TREATING BCL-2 PROTEIN RELATED DISEASES
摘要 ABT-263 free base and crystalline forms thereof are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
申请公布号 KR20120085781(A) 申请公布日期 2012.08.01
申请号 KR20127010148 申请日期 2010.09.15
申请人 ABBOTT LABORATORIES 发明人 ZHANG GEOFF G.Z;BRACKEMEYER PAUL J.;CATRON NATHANIEL D.;BORCHARDT THOMAS B.
分类号 C07D413/12;A61K31/5377;A61P35/00;C07D295/155 主分类号 C07D413/12
代理机构 代理人
主权项
地址